Consistently, the activation of the Akt/mTOR pathway decreased with ALO treatment in NSCLC cells in vitro and mouse tumor models in vivo, whereas the levels of Beclin‐1 and ATG7 increased (Figure S6, Supporting Information), indicating that ALO may promote autophagosome formation by interfering with the Akt/mTOR pathway. The gene discussed is MTOR; the disease is non-small cell lung carcinoma.